4.5 Review

Signaling factors in the mechanism of ammonia neurotoxicity

期刊

METABOLIC BRAIN DISEASE
卷 24, 期 1, 页码 103-117

出版社

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11011-008-9113-6

关键词

Astrocytes; Ammonia; Hepatic encephalopathy; Mitochondrial permeability transition; Mitogen-activated protein kinases; NF-kappa B; Oxidative/nitrosative stress

资金

  1. Merit Review from the Department of Veterans Affairs
  2. National Institutes of Health [DK063311]
  3. American Association for the Study of Liver Disease/American Liver Foundation
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063311] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Mechanisms involved in hepatic encephalopathy (HE) still remain poorly understood. It is generally accepted that ammonia plays a major role in this disorder, and that astrocytes represent the principal target of ammonia neurotoxicity. In recent years, studies from several laboratories have uncovered a number of factors and pathways that appear to be critically involved in the pathogenesis of this disorder. Foremost is oxidative and nitrosative stress (ONS), which is largely initiated by an ammonia-induced increase in intracellular Ca2+. Such increase in Ca2+ activates a number of enzymes that promote the synthesis of reactive oxygen-nitrogen species, including constitutive nitric oxide synthase, NADPH oxidase and phospholipase A2. ONS subsequently induces the mitochondrial permeability transition, and activates mitogen-activated protein kinases and the transcription factor, nuclear factor-kappaB (NF-kappa B). These factors act to generate additional reactive oxygen-nitrogen species, to phosphorylate various proteins and transcription factors, and to cause mitochondrial dysfunction. This article reviews the role of these factors in the mechanism of HE and ammonia toxicity with a focus on astrocyte swelling and glutamate uptake, which are important consequences of ammonia neurotoxicity. These pathways and factors provide attractive targets for identifying agents potentially useful in the therapy of HE and other hyperammonemic disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据